Stoke Therapeutics, Inc., a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, announced the appointment of Eric...
Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, announced the close...
LumaCyte, a leader in advanced cellular analysis and precision bioanalytics, proudly announces the launch of its groundbreaking cell therapy application for predictive CAR T...
Rigaku Corporation, a Rigaku Holdings Group company and global partner for lab-to-factory X-ray analysis, has developed a patent-pending technology called Electron Density Topography (EDT)....
Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, announces the appointment of Antony Mattessich as its Chief Executive Officer (CEO)...
